Related references
Note: Only part of the references are listed.Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation
Sarah-Fee Katz et al.
GASTROENTEROLOGY (2012)
High-mobility Group Box 1 is Associated with Clinicopathologic Features in Patients with Hepatocellular Carcinoma
Wei Jiang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
HMGB1 cytoplasmic translocation in patients with acute liver failure
Rong-Rong Zhou et al.
BMC GASTROENTEROLOGY (2011)
What Is the Role of the Receptor for Advanced Glycation End Products-Ligand Axis in Liver Injury?
Giuseppina Basta et al.
LIVER TRANSPLANTATION (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo
David Frommhold et al.
BLOOD (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
Xin-Rong Yang et al.
GUT (2010)
High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity
John Evankovich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The expression of HMGB1 protein and its receptor RAGE in human malignant tumors
Nora Kostova et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Toll-like Receptor 4 and Hepatic Fibrogenesis
Jean-Philippe Pradere et al.
SEMINARS IN LIVER DISEASE (2010)
Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?
Ayse Albayrak et al.
VIRAL IMMUNOLOGY (2010)
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Johannes Haybaeck et al.
CANCER CELL (2009)
The receptor RAGE: Bridging inflammation and cancer
Astrid Riehl et al.
CELL COMMUNICATION AND SIGNALING (2009)
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
A. Bierhaus et al.
DIABETOLOGIA (2009)
Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury
Shan Zeng et al.
JOURNAL OF HEPATOLOGY (2009)
S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2
Saeld Ghavami et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Contradictory functions of NF-κB in liver physiology and cancer
Gilad W. Vainer et al.
CANCER LETTERS (2008)
Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound
Matthew M. Jellicoe et al.
CARCINOGENESIS (2008)
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
Olga Turovskaya et al.
CARCINOGENESIS (2008)
High-mobility group box-1 in ischemia-reperfusion injury of the heart
Martin Andrassy et al.
CIRCULATION (2008)
S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products
John H. Boyd et al.
CIRCULATION RESEARCH (2008)
Advanced glycation end products (AGEs) and their involvement in liver disease
Hideyuki Hyogo et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats
Jin-Rong Xia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
RAGE signaling sustains inflammation and promotes tumor development
Christoffer Gebhardt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma
Vicencia M. R. de Lima et al.
JOURNAL OF HEPATOLOGY (2008)
A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC
Kiyokazu Hiwatashi et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Kupffer cell heterogeneity: functional properties of bone marrow-derived and sessile hepatic macrophages
Ingo Klein et al.
BLOOD (2007)
Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: Potential roles of early DNA damage and liver metallothionein expression
Tnidib Chakraborty et al.
LIFE SCIENCES (2007)
Isolation, culture and immortalisation of hepatic oval cells from adult mice fed a choline-deficient, ethionine-supplemented diet
Janina E. E. Tirnitz-Parker et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice
M Katzenellenbogen et al.
CANCER RESEARCH (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice
U Ekong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Liver inflammation and cytokine production,but not acute phase protein synthesis, accompany the adult liverprogenitor (oval) cell response to chronic liver injury
B Knight et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury
AV Kofman et al.
HEPATOLOGY (2005)
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
A Tsung et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
RAGE limits regeneration after massive liver injury by coordinated suppression TNF-α and NF-κB
G Cataldegirmen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Liver stem cells - Implications for hepatocarcinogenesis
Malcolm R. Alison
STEM CELL REVIEWS (2005)
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice
S Zeng et al.
HEPATOLOGY (2004)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Molecular viral oncology of hepatocellular carcinoma
TM Block et al.
ONCOGENE (2003)
A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver
B Akhurst et al.
HEPATOLOGY (2001)
Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice
B Knight et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Share Paper
